Falkenhorst, J., Ivanyi, P., Schulz, T., Hamacher, R., Kasper, B., Hohenberger, P., . . . Bauer, S. (2025). Phase II trial of ponatinib in patients with metastatic gastrointestinal stromal tumor following failure or intolerance of prior therapy with imatinib (POETIG Trial): Clinical cancer research : clinical trials : targeted therapy. Clinical cancer research, 31(19), . https://doi.org/10.1158/1078-0432.CCR-25-0222
Chicago-Zitierstil (17. Ausg.)Falkenhorst, Johanna, et al. "Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor Following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial): Clinical Cancer Research : Clinical Trials : Targeted Therapy." Clinical Cancer Research 31, no. 19 (2025). https://doi.org/10.1158/1078-0432.CCR-25-0222.
MLA-Zitierstil (9. Ausg.)Falkenhorst, Johanna, et al. "Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor Following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial): Clinical Cancer Research : Clinical Trials : Targeted Therapy." Clinical Cancer Research, vol. 31, no. 19, 2025, https://doi.org/10.1158/1078-0432.CCR-25-0222.